This did not pass his technical screen, as there were consistent earnings misses. Drug pricing is under a gun and is just not something you want to step in front of.
Stock price when the opinion was issued
Build your watch list
Sign in to track investmentsyou care about
Stockchase Premium
Newhaven Asset Management
Rule Investment Media
5i Research
CNBC
This did not pass his technical screen, as there were consistent earnings misses. Drug pricing is under a gun and is just not something you want to step in front of.